The Anti-Oxidative Capacity of High-Density Lipoprotein Is Reduced in Acute Coronary Syndrome But Not in Stable Coronary Artery Disease (Q82332806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22051328%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22051328%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

The Anti-Oxidative Capacity of High-Density Lipoprotein Is Reduced in Acute Coronary Syndrome But Not in Stable Coronary Artery Disease (English)

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

16 December 2024

main subject

acute coronary syndrome

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

Kashif Jafri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22051328%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Parin J. Patel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22051328

16 December 2024

Amit V. Khera

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22051328

16 December 2024

Robert L. Wilensky

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22051328

16 December 2024

Daniel J. Rader

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22051328

16 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22051328

16 December 2024

publication date

1 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22051328%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

8 November 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22051328

full work available at URL

16 December 2024

https://doi.org/10.1016/j.jacc.2011.08.030

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22051328

https://api.elsevier.com/content/article/PII:S0735109711031378?httpAccept=text/xml

16 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

https://api.elsevier.com/content/article/PII:S0735109711031378?httpAccept=text/plain

16 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Journal of the American College of Cardiology

16 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22051328%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22051328%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22051328%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

2068-2075

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22051328%20AND%20SRC:MED&resulttype=core&format=json

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

15 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Prediction of Coronary Heart Disease Using Risk Factor Categories

16 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control

16 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Effects of torcetrapib in patients at high risk for coronary events

16 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene

16 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly

16 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study

16 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches

16 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Molecular regulation of HDL metabolism and function: implications for novel therapies

16 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Antiatherogenic functionality of high density lipoprotein: how much versus how good

16 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

16 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

16 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis

16 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Can dysfunctional HDL explain high coronary artery disease risk in South Asians?

16 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

HDL-inflammatory index correlates with poor outcome in hemodialysis patients

16 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.

16 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide

16 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Apolipoprotein A-I inhibits chemotaxis, adhesion, activation of THP-1 cells and improves the plasma HDL inflammatory index

16 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.

16 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans

16 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography

16 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Effect of HDL composition and particle size on the resistance of HDL to the oxidation

16 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction

16 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants

16 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans

16 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36.

16 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography

16 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia

16 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis

16 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Oxidative stress as the leading cause of acute myocardial infarction in diabetics

16 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

The free oxygen radicals test (FORT) to assess circulating oxidative stress in patients with acute myocardial infarction

16 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).

16 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary artery disease

16 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes

16 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Fractional esterification rate of HDL particles in patients with type 2 diabetes. Relation to coronary heart disease risk factors

16 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

HDL-cholesterol level provides additional prognosis in acute coronary syndromes

16 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines

16 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation

16 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides

16 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein

16 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

16 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

HDL dysfunction in obstructive sleep apnea.

16 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity

16 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity

16 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

Combined statin and niacin therapy remodels the high-density lipoprotein proteome

16 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JACC.2011.08.030

16 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22051328%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference